Hyperkalemia during treatment with HMG-CoA reductase inhibitor

N Engl J Med. 1989 May 4;320(18):1219-20. doi: 10.1056/nejm198905043201818.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 1 / complications
  • Humans
  • Hyperkalemia / chemically induced*
  • Hyperlipoproteinemia Type II / drug therapy
  • Hypertension / complications
  • Kidney Diseases / complications
  • Lovastatin / adverse effects*
  • Male

Substances

  • Lovastatin